Showing results (21-30 of 66) with videos related to

Sort By:
Pageof 7
Cancer Chemotherapy and Pharmacology|January 1, 1989
Prolongation of ifosfamide elimination half-life in obese patients due to altered drug distributionM J Lind, J M Margison, T Cerny, et al.
Xenobiotica; the Fate of Foreign Compounds in Biological Systems|July 1, 1992
Value of early pharmacodynamic and pharmacokinetic investigations with anticancer drugs: data from phase I tolerance studies on a new vinca alkaloid derivativeR M Ings, E Lelièvre, C Ardiet, et al.
Anti-Cancer Drugs|February 1, 1995
Phase I and pharmacokinetic study of a novel mitomycin C analog KW-2149L Dirix, G Catimel, I Koier, et al.
International Journal of Cancer|March 12, 1992
Confluence-dependent resistance in human colon cancer cells: role of reduced drug accumulation and low intrinsic chemosensitivity of resting cellsM T Dimanche-Boitrel, H Pelletier, P Genne, et al.
Cancer Chemotherapy and Pharmacology|January 1, 1990
Therapy for poor-risk patients with small-cell lung cancer using bolus ifosfamide and oral etoposideH Anderson, M J Lind, N Thatcher, et al.
Bone Marrow Transplantation|April 21, 2001
Pharmacodynamics of tandem high-dose melphalan with peripheral blood stem cell transplantation in children with neuroblastoma and medulloblastomaG Vassal, B Tranchand, D Valteau-Couanet, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|April 13, 2000
Multivariable analysis of prognostic factors for toxicity and survival for patients enrolled in phase I clinical trialsT Bachelot, I Ray-Coquard, G Catimel, et al.
European Journal of Cancer (Oxford, England : 1990)|July 4, 2001
A phase II study of pemetrexed disodium (LY231514) in patients with locally recurrent or metastatic breast cancerD W Miles, I E Smith, R E Coleman, et al.
Hematological Oncology|January 1, 1989
Cyclosporin associated demyelination following allogeneic bone marrow transplantationM J Lind, L McWilliam, J Jip, et al.
British Journal of Obstetrics and Gynaecology|March 1, 1989
The role of postoperative alkylating agent therapy in early-stage epithelial ovarian cancerJ Mackintosh, C H Buckley, V R Tindall, et al.
Pageof 7